P502A pilot study to assess effects of mobilized endothelial progenitor cell for ischemic heart disease

    loading  Checking for direct PDF access through Ovid



Endothelial progenitor cells (EPCs) may promote neovascularization in patients with coronary artery disease (CAD). Mobilized EPCs by granulocyte colony-stimulating factor (G-CSF) might increase the exercise duration and improve exercise-induced ST depression in patients with chronic CAD.


Granulocyte colony-stimulating factor (G-CSF), 2.5 mg/kg/day for five days, was administered to 10 patients with CAD. Ischemia was assessed by treadmill exercise testing. The effects of G-CSF on blood were measured by auto hematology analyzer and semi-auto chemistry analyzer.


Granulocyte colony-stimulating factor increased the white blood cells (x103/ml) in the circulation from 7.0 ± 0.7 to 19.5 ± 2.2 (p < 0.001). Indices of platelets, hemoglobin, alanine aminotransferase, lactic dehydrogenase, and uric acid were not changed by treatment. The exercise duration after 1 month increased from 4.2 ± 0.49 to 5.8 ± 0.71 (p < 0.005) and disappearance of exercise-induced ST depression compared with baseline. Three patients reported mild myalgia which were easily managed with acetoaminophen.


The findings show that granulocyte colony-stimulating factor mobilizes stem cells from bone marrow in patients with coronary artery disease and improve treadmill exercise testing. The therapeutic strategy was safe and tolerable in patients with CAD.

Related Topics

    loading  Loading Related Articles